Astellas

Astellas Pharma UK is the British subsidiary of the Japanese pharmaceutical company Astellas, developing innovative medicines in urology, oncology, and transplantation. Key products include XTANDI (enzalutamide) for metastatic and non-metastatic castration-resistant prostate cancer, Prograf and Advagraf (tacrolimus) for transplant rejection prevention in kidney, liver, and heart transplant patients, and Betmiga (mirabegron) for overactive bladder syndrome. Medical Information: 0800 783 5018.